BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25985182)

  • 1. GH Receptor Deficiency in Ecuadorian Adults Is Associated With Obesity and Enhanced Insulin Sensitivity.
    Guevara-Aguirre J; Rosenbloom AL; Balasubramanian P; Teran E; Guevara-Aguirre M; Guevara C; Procel P; Alfaras I; De Cabo R; Di Biase S; Narvaez L; Saavedra J; Longo VD
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2589-96. PubMed ID: 25985182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity.
    Guevara-Aguirre J; Teran E; Lescano D; Guevara A; Guevara C; Longo V; Gavilanes AWD
    Growth Horm IGF Res; 2020 Apr; 51():58-64. PubMed ID: 32145513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Despite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives.
    Guevara-Aguirre J; Procel P; Guevara C; Guevara-Aguirre M; Rosado V; Teran E
    Growth Horm IGF Res; 2016 Jun; 28():76-8. PubMed ID: 26259979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency.
    Bachrach LK; Marcus R; Ott SM; Rosenbloom AL; Vasconez O; Martinez V; Martinez AL; Rosenfeld RG; Guevara-Aguirre J
    J Bone Miner Res; 1998 Mar; 13(3):415-21. PubMed ID: 9525342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
    Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
    Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Structure and Function Associated with Younger Adults in Growth Hormone Receptor-Deficient Humans.
    Nashiro K; Guevara-Aguirre J; Braskie MN; Hafzalla GW; Velasco R; Balasubramanian P; Wei M; Thompson PM; Mather M; Nelson MD; Guevara A; Teran E; Longo VD
    J Neurosci; 2017 Feb; 37(7):1696-1707. PubMed ID: 28073935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MECHANISMS IN ENDOCRINOLOGY: Transient juvenile hypoglycemia in growth hormone receptor deficiency - mechanistic insights from Laron syndrome and tailored animal models.
    Hinrichs A; Renner S; Bidlingmaier M; Kopchick JJ; Wolf E
    Eur J Endocrinol; 2021 Jul; 185(2):R35-R47. PubMed ID: 34048365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity is increased and fat oxidation after a high-fat meal is reduced in normal-weight healthy men with strong familial predisposition to overweight.
    Giacco R; Clemente G; Busiello L; Lasorella G; Rivieccio AM; Rivellese AA; Riccardi G
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):342-8. PubMed ID: 14970841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitivity is increased and fat oxidation after a high-fat meal is reduced in normal-weight healthy men with strong familial predisposition to overweight.
    Giacco R; Clemente G; Busiello L; Lasorella G; Rivieccio AM; Rivellese AA; Riccardi G
    Int J Obes Relat Metab Disord; 2003 Jul; 27(7):790-6. PubMed ID: 12821963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
    Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokines, ghrelin and obesity-associated insulin resistance in nondiabetic patients with acute coronary syndrome.
    Barazzoni R; Aleksova A; Armellini I; Cattin MR; Zanetti M; Carriere C; Giacca M; Dore F; Guarnieri G; Sinagra G
    Obesity (Silver Spring); 2012 Dec; 20(12):2348-53. PubMed ID: 22653312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency.
    Guevara-Aguirre J; Rosenbloom AL
    Diabetologia; 2015 Jan; 58(1):37-42. PubMed ID: 25316432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients.
    Ciresi A; Amato MC; Pizzolanti G; Giordano Galluzzo C
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2907-15. PubMed ID: 22679062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.